Week 96 extension results of a Phase 3 study evaluating long-acting cabotegravir with rilpivirine for HIV-1 treatment-Reference-Cited by-同舟云学术

Week 96 extension results of a Phase 3 study evaluating long-acting cabotegravir with rilpivirine for HIV-1 treatment

Published:2021-07-13 Issue:2 Volume:36 Page:185-194
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Swindells Susan,Lutz Thomas,Van Zyl Lelanie,Porteiro Norma,Stoll Matthias,Mitha Essack,Shon Alyssa,Benn Paul,Huang Jenny O.,Harrington Conn M.,Hove Kai,Ford Susan L.,Talarico Christine L.,Chounta Vasiliki,Crauwels Herta,Van Solingen-Ristea Rodica,Vanveggel Simon,Margolis David A.,Smith Kimberly Y.,Vandermeulen Kati,Spreen William R.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference21 articles.

1. Experiences with long acting injectable ART: a qualitative study among PLHIV participating in a phase II study of cabotegravir + rilpivirine (LATTE-2) in the United States and Spain;Kerrigan;PLoS One,2018

2. The critical need for alternative antiretroviral formulations, and obstacles to their development;Swindells;J Infect Dis,2011

3. Patient-reported barriers to adherence to antiretroviral therapy: a systematic review and meta-analysis;Shubber;PLoS Med,2016

4. 1329. Experiences and emotional challenges of antiretroviral treatment (ART)—findings from the Positive Perspectives Study;De Los Rios;Open Forum Infect Dis,2019

5. The evolution of three decades of antiretroviral therapy: challenges, triumphs and the promise of the future;Tseng;Br J Clin Pharmacol,2015

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early Implementation and Outcomes Among People with HIV Who Accessed Long-Acting Injectable Cabotegravir/Rilpivirine at Two Ryan White Clinics in the U.S. South;AIDS Research and Human Retroviruses;2024-07-16

2. Ensuring People Living with HIV Inform the Future of HIV Treatment in Low- and Middle-Income Countries: A Scoping Review and Recommendations for a Community-Led Research Agenda;AIDS and Behavior;2024-07-11

3. Consensus recommendations for use of long‐acting antiretroviral medications in the treatment and prevention of HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases Pharmacists;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2024-07

4. Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain;AIDS Patient Care and STDs;2024-07-01

5. One Year of Long-Acting Cabotegravir and Rilpivirine in People With Human Immunodeficiency Virus and Long Exposure to Antiretroviral Therapy: Data From the SCohoLART Study;Open Forum Infectious Diseases;2024-06-20